Search Results 61-70 of 27323 for colitis
Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis · Share · Facebook · Twitter.
About this study. The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC).
The purpose of this study is to evaluate the safety, effectovemess, and microbiota changes of VE202 in patients with mild to moderate ulcerative colitis (UC).
... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
Mesalamineenema is used to treat active mild to moderate ulcerative colitis, proctitis or proctosigmoiditis (inflammation of the rectum and bowel). It works ...
... colon, which had developed several sites with precancerous cells related to his ulcerative colitis, which was first diagnosed in 1997. Scott had previously ...
The Relationship Between Endoscopic Inflammation and Health-related Quality of Life in Patients with Ulcerative Colitis · More about research at Mayo Clinic.
Colon ischemia (ischemic colitis) affects the large intestine. Types of ischemia that affect the small intestine include acute mesenteric ischemia, chronic ...
Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis · More about research at Mayo Clinic · Mayo ...
Gastroenterologist. Rochester, MN. Areas of focus: Ulcerative colitis, Inflammatory bowel disease, Microscopic colitis, Collagenous colitis, C. difficile ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.